The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells
- 1 August 2001
- journal article
- research article
- Published by Wiley in Xenotransplantation
- Vol. 8 (3), 202-212
- https://doi.org/10.1034/j.1399-3089.2001.0o108.x
Abstract
The chronic shortage of human organs, tissues and cells for transplantation has inspired research on the possibility of using animal donor tissue instead. Transplantation over a species barrier is associated with rejections which are difficult to control. Therefore, it is generally agreed that successful pig to human xenotransplantation requires donor pigs to be genetically modified. Vascular endothelium is the most immediate barrier between the xenogeneic donor organ and host immune and nonimmune defense systems. Thus, these cells are the prime targets for such genetic modifications. Luciferase assays were used to evaluate the activity and specificity of human endothelial-cell specific promoters in porcine aortic-, microvascular- and nonendothelial cells. The promoters for human Flk-1 (fetal liver kinase-1), Flt-1 (fms-like tyrosine kinase), ICAM-2 (intercellular adhesion molecule-2), thrombomodulin and vWf (von Willebrand factor) supported similar levels of luciferase expression in human and porcine aortic endothelial cells, with the Flk-1 promoter being the strongest followed by the thrombomodulin promoter. Relative to the activity of the CMV promoter, the human endothelial cell-specific promoters all showed less activity in porcine kidney microvascular endothelial cells than in liver or brain microvascular endothelial cells. The thrombomodulin and Flk-1 promoters exhibited similar activity in liver and kidney microvascular endothelial cells, whereas the Flk-1 promoter was stronger in aortic and brain microvascular endothelial cells. Human endothelial cell-specific promoters also showed some degree of specificity in pig, because they supported less luciferase activity in porcine nonendothelial cell lines. Based on the in vitro data and previously published in vivo data, the human Flk-1 and thrombomodulin promoters are good candidate promoters for strong endothelial cell-specific gene expression in transgenic pigs.Keywords
This publication has 46 references indexed in Scilit:
- The Human ICAM-2 Promoter is Endothelial Cell-specific in Vitro and in Vivo and Contains Critical Sp1 and GATA Binding SitesJournal of Biological Chemistry, 1998
- XENOGENEIC TRANSPLANTATIONAnnual Review of Immunology, 1998
- REMOVAL OF XENOREACTIVE HUMAN ANTI-PIG ANTIBODIES BY ABSORPTION ON RECOMBINANT MUCIN-CONTAINING GLYCOPROTEINS CARRYING THE GAL??1,3GAL EPITOPE1Transplantation, 1997
- TARGETING GENE EXPRESSION TO ENDOTHELIAL CELLS IN TRANSGENIC MICE USING THE HUMAN INTERCELLULAR ADHESION MOLECULE 2 PROMOTER1Transplantation, 1996
- CHARACTERIZATION OF TRANSGENIC PIGS EXPRESSING FUNCTIONALLY ACTIVE HUMAN CD59 ON CARDIAC ENDOTHELIUMTransplantation, 1996
- TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY-ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTIONTransplantation, 1995
- Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.JCI Insight, 1995
- Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytesCell, 1989
- Endothelial Leukocyte Adhesion Molecule 1: an Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and LectinsScience, 1989
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986